Gilead launches global ALL4LIVER grant program to help achieve the world health organization’s goal of viral hepatitis elimination by 2030. Gilead Sciences, Inc. (Nasdaq: GILD)
WIRES* has announced a $5million grant program to improve outcomes for Australia’s native wildlife. WIRES National Grant Program will be run over five years and